Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
50 /100
MEDIUM RISK
Score updated Oct 13, 2026

RGC — Regencell Bioscience Holdings Limited Dilution Risk Tracker

Track RGC dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track RGC — Get alerts when the score changes →

As of October 13, 2026, Regencell Bioscience Holdings Limited (RGC) has a DilutionWatch DilutionScore of 50/100, rated MEDIUM dilution risk. Regencell Bioscience Holdings Limited has a market capitalization of $3.54B, 495.88M shares outstanding, 35 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
40
📊 Float Risk
67
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 7%
📉 Score Deterioration model 15%
• Score climbed 9 points (worsening)
🔔 Track RGC — Get forecast alerts →

Market Data

Market Cap$3.54B
Shares Outstanding495.88M
Float55.41M
Cash$8.89M
Debt$3.00M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore50/100DilutionWatch score record
Shares Outstanding495.88MVerified float table or market cache
Public Float55.41MVerified float table or market cache
Market Cap$3.54BMarket data cache
Cash Runway13.9 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 2.

Recent SEC source mix: XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 32.8% shares (2026Q1 vs prior)
35 institutional holders · 878.0K shares
#1 GEODE CAPITAL MANAGEMENT, LLC 415.6K shares
#2 MORGAN STANLEY 79.3K shares
#3 SUSQUEHANNA INTERNATIONAL GROUP, LLP 72.7K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest656.2K
Days to Cover7.3
% of Float1.2%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-10-07
xbrl XBRL CONVERTIBLE 2024-10-25
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual RGC Dilution Snapshot

Regencell Bioscience Holdings Limited (RGC) has a DilutionScore of 50/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

RGC's DilutionScore is currently 50/100 (Medium risk), with 1 score change tracked over 89 days. The score improved from 41/100 (Medium risk).

Period Score Risk Level Duration
Oct 12 – Oct 13, 202650/100MEDIUM2 days
Jul 16 – Oct 11, 202641/100MEDIUM87 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

RGC shares outstanding have decreased 0.0% from 494.49M (Mar 2026) to 494.49M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 02, 2026494.49M55.41M▲ 26.10%
Apr 07, 2026494.49M43.94M▼ 20.70%
Apr 01, 2026494.49M55.41M▲ 221.24%
Mar 26, 2026494.49M17.25M▼ 3.27%
Mar 24, 2026494.49M17.83M▼ 3.27%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track RGC Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment RGC files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking RGC — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for RGC
RGC FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.